Loading clinical trials...
Loading clinical trials...
A study to evaluate the safety and tolerability of INCA036873 in participants with advanced solid tumors and hematological malignancies.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Incyte Corporation
NCT04570423 · Solid Tumors, Lymphoma
NCT06926283 · Prostate Cancer, Other Solid Tumors, and more
NCT07177937 · Small Cell Lung Cancer, Melanoma, and more
NCT07489378 · Very Rare Tumors, Very Rare Cancers, and more
NCT07181681 · Solid Tumors, Advanced Solid Tumor
City of Hope Medical Center
Duarte, California
University of California San Diego Medical Center, Moores Cancer Center
La Jolla, California
University of Michigan
Ann Arbor, Michigan
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions